Arbutus Biopharma Corporation Stock price
Compare with Peer Group
Is Arbutus Biopharma Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,102 stocks worldwide.
Key metrics
Arbutus Biopharma Corporation Stock Analysis
Analyst Opinions
7 Analysts have issued a Arbutus Biopharma Corporation forecast:
Analyst Opinions
7 Analysts have issued a Arbutus Biopharma Corporation forecast:
Don't miss a Thing! We will send you all news about Arbutus Biopharma Corporation directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Arbutus Biopharma Corporation Stock News
Company Profile
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
| Head office | Canada |
| CEO | Ms. Androski |
| Employees | 19 |
| Founded | 2005 |
| Website | www.arbutusbio.com |


